Dasan Medichem

Dasan Medichem is a South Korean pharmaceutical company specializing in the development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. The company focuses on value-added generics and Incrementally Modified Drugs (IMDs), utilizing advanced formulation technologies such as drug delivery systems (DDS) and micro-pellet coating. Their service offerings include contract development and manufacturing (CDMO) for global partners, with a strong emphasis on quality control and regulatory compliance. Dasan Medichem operates multiple R&D centers and manufacturing facilities to support its diverse portfolio across cardiovascular, gastrointestinal, and central nervous system therapeutic areas. The company is recognized for its expertise in creating fixed-dose combination therapies that improve patient compliance and therapeutic efficacy.